CFTR and cystic fibrosis: The in vitro findings indicating that CF airway epithelial inflammation enhances the efficacy of CFTR modulators, together with the initially predicted [32] and the recently found positive correlation between airway inflammation and enhanced CFTR modulator-improved lung function in CF patients [60], have implications for the clinic.